Literature DB >> 31403870

Is There a Role for Intraperitoneal Chemotherapy, Including HIPEC, in the Management of Ovarian Cancer?

Ignace Vergote1, Philipp Harter2, Luis Chiva3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31403870     DOI: 10.1200/JCO.19.00091

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  History of intraperitoneal platinum drug delivery for ovarian cancer and its future applications.

Authors:  Franco Muggia; Andrea Bonetti
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 2.  First-Line Management of Advanced High-Grade Serous Ovarian Cancer.

Authors:  Reem D Mahmood; Robert D Morgan; Richard J Edmondson; Andrew R Clamp; Gordon C Jayson
Journal:  Curr Oncol Rep       Date:  2020-06-04       Impact factor: 5.075

3.  Pharmacokinetics and toxicity of carboplatin used for hyperthermic intraperitoneal chemotherapy (HIPEC) in treatment of epithelial ovarian cancer.

Authors:  Mette Schou Mikkelsen; Jan Blaakaer; Lone Kjeld Petersen; Luise Gram Schleiss; Lene Hjerrild Iversen
Journal:  Pleura Peritoneum       Date:  2020-09-07

4.  The impact of hyperthermic intraperitoneal chemotherapy and cytoreductive surgery on clinical outcomes and quality of life of patients with peritoneal carcinomatosis.

Authors:  Oleksandr Vadymovych Bondar; Serhii Hennadiiovych Chetverikov; Viacheslav Yevheniiovych Maksymovskyi; Dmytro Vadymovych Atanasov; Valeriia Volodymyrivna Chetverikova-Ovchynnyk; Mykhailo Serhiiovych Chetverikov
Journal:  Contemp Oncol (Pozn)       Date:  2021-12-29

5.  Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.

Authors:  Thanh H Dellinger; Ernest S Han; Mustafa Raoof; Byrne Lee; Xiwei Wu; Hyejin Cho; Ting-Fang He; Peter Lee; Marianne Razavi; Winnie S Liang; Daniel Schmolze; Saul J Priceman; Stephen Lee; Wei-Chien Lin; Jeff F Lin; Mehdi Kebria; Amy Hakim; Nora Ruel; Daphne B Stewart; Edward W Wang; Benjamin I Paz; Mark T Wakabayashi; Mihaela C Cristea; Lorna Rodriguez-Rodriguez
Journal:  JCO Precis Oncol       Date:  2022-03

Review 6.  Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers.

Authors:  Pei-Qi Lim; I-Hung Han; Kok-Min Seow; Kuo-Hu Chen
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

Review 7.  Past, Present, and Future of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer.

Authors:  Mona Mishra; Nilanchali Singh; Prafull Ghatage
Journal:  Cureus       Date:  2021-06-10

8.  Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data.

Authors:  Shalkar Adambekov; Samia Lopa; Robert P Edwards; Lara Lemon; Shu Wang; Sarah E Taylor; Brian Orr; Faina Linkov
Journal:  Cancer Med       Date:  2020-08-19       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.